|
Industry
Solution: Nuclear
Medicine
The growing use of short
half life isotopes in PET
imaging has created new and
more stringent requirements
for timely and safe
transport of radioisotopes
from the production site to
the point of end use.
The need to provide
dependable protection
against the more penetrating
511 keV radiation has
additionally dictated the
use of thicker shielding
than needed for many of the
nuclear medical procedures
of the past. While
lead has been the
predominant shielding
material and still enjoys
widespread use, many nuclear
pharmacies and end users
alike have opted for
lead-free shielding
materials in view of the
recognized toxicity of lead.
An attractive aspect of
tungsten-based shielding is
the freedom from materials
accountability concerns
related to the use of lead
in returnable shipping
containers. In
recognition of these needs
within the
nuclear medicine community,
ATI Firth Sterling has
developed a proprietary line
of tungsten heavy alloy vial
shields for PET isotopes
that offer a number of
benefits.
We are innovating the
products of tomorrow to
create effective, safe, efficient
solutions for you. |
To improve your productivity
Contact the
Experts